Immunology

T-cell vaccine for COVID-19 may last longer than current vaccines

The current COVID-19 vaccines are designed to trigger an antibody response to the SARS-CoV-2 spike protein, which is vulnerable to mutations that could make the vaccine less effective over time. Focusing on the T-cell instead, ...

Oncology & Cancer

Breast cancer vaccine study begins with first patient

An innovative study of a breast cancer vaccine is officially underway, as University of Pittsburgh Medical Center announced on June 20 that the first participant had received her full course of the vaccine.

page 10 from 40